Subscribe To
Phio Pharmaceuticals Announces Dosing of First Patient in Collaborative Clinical Trial with AgonOx, Inc. and Providence Cancer Institute
Trial targeting treatment of metastatic melanoma and other solid tumors MARLBOROUGH, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today announced that its clinical development partners, AgonOx, Inc. […] The post Phio Pharmaceuticals Announces Dosing of First Patient in Collaborative Clinical Trial...
Read More
Content Topics
Phio
Pharmaceuticals
Announces
Dosing
First
Patient
Collaborative
Clinical
Agonox
Providence
Cancer
Institute
Forex
Posted: Aug 21 2023, 11:30
Author Name: forextv
Views: 092156